Christopher Toombs
Directeur/Membre du Conseil chez IKARIA, INC.
Postes actifs de Christopher Toombs
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| IKARIA, INC. | Directeur/Membre du Conseil | 01/03/2006 | - |
Faraday Pharmaceuticals, Inc.
 Faraday Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Faraday Pharmaceuticals, Inc. engages in the research and development of elemental reducing agents (ERAs). Its therapeutic agents have potential applications for treatment of critical care illnesses. The company was founded by Mark B. Roth and Christopher Toombs in 2014 and is headquartered in Seattle, WA. | Directeur Technique/Scientifique/R&D | 01/01/2014 | - |
| Fondateur | 01/01/2014 | - | |
Proniras Corp.
 Proniras Corp. BiotechnologyHealth Technology Proniras Corp. operates as a bio technology company. The company is headquartered in Seattle, WA. | Fondateur | 01/01/2018 | - |
| Corporate Officer/Principal | 01/01/2018 | - | |
Accelerator Services Corp
 Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington. | Private Equity Investor | - | - |
Historique de carrière de Christopher Toombs
Anciens postes connus de Christopher Toombs
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| MuciMed, Inc. | Private Equity Investor | 01/03/2014 | 30/06/2016 |
Formation de Christopher Toombs
| Wake Forest School of Medicine | Doctorate Degree |
| Wheaton College Graduate School | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 8 |
Opérationnelle
| Founder | 2 |
| Private Equity Investor | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 3 |
| Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 5 |
|---|---|
| MuciMed, Inc. | |
Ikaria, Inc.
 Ikaria, Inc. BiotechnologyHealth Technology Ikaria, Inc. operates as a biotherapeutics company focused on developing and commercializing innovative therapeutics and interventions designed to meet the medical needs of critically ill patients. It offers INOMAX for inhalation, which is used to treat newborns suffering from hypoxic respiratory failure, and is making a major impact on the critical care environment. The company was founded on August 18, 2006 and is headquartered in Clinton, NJ. | Health Technology |
Accelerator Services Corp
Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington. | Finance |
Faraday Pharmaceuticals, Inc.
Faraday Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Faraday Pharmaceuticals, Inc. engages in the research and development of elemental reducing agents (ERAs). Its therapeutic agents have potential applications for treatment of critical care illnesses. The company was founded by Mark B. Roth and Christopher Toombs in 2014 and is headquartered in Seattle, WA. | Health Technology |
Proniras Corp.
Proniras Corp. BiotechnologyHealth Technology Proniras Corp. operates as a bio technology company. The company is headquartered in Seattle, WA. | Health Technology |
- Bourse
- Insiders
- Christopher Toombs
- Expérience
